Nanjing Cheil Hospital (Nanjing Medical University Nanjing Hospital, Nanjing Cheil Hospital Chinese Pharmaceutical University) is a general hospital. It has been designated as the third clinical medical school of Nanjing University of Medicine and has a high level of technical skill in cardiovascular diseases and stroke. It is the national drug clinical trial institution, the first national heart transplant hospital, the first national injury rehabilitation pilot institution, There are National Health Care Basic Health Training Base of Hypertrophy, Coronary Artery Intervention, Coronary Bypass, Cardiac Surgeon China Training Base, Medical Endoscopy Skill Training Base, Nanjing Diabetes Prevention Center, Nuclear Medicine Center and Nanjing Red Cross Eye Bank.

  The hospital was established in February 1936, with a staff of 3,000 and a sickness of 2,000. In 2017, the total number of treatments was 1.3 million, and the number of hospital discharge was 72,000. More than 106 instruments and advanced medical equipment including PET-CT, isotope single photon emission computed tomography (ECT), cardiovascular imaging system (DSA), advanced dual source CT, And 3.0T magnetic resonance tomography system, linear accelerator system, digital X-ray imaging system (DR), high-energy ultrasound focusing system, optical coherence tomography system and digital operating room system.